Diabetes Clinical Trials in Arizona

Showing 261-280 of 495 trials

Epigenetics and the Origin of Muscle Insulin Resistance in Humans

NCT01726491

The investigators are trying to understand the role of DNA (deoxyribonucleic acid) methylation in insulin resistance in skeletal muscle and blood tissues. DNA methylation is a normal chemical process in the body that modifies DNA. By studying this, the investigators hope to better understand the causes of insulin resistance.

Diabetes Mellitus Type 2 in ObeseObesity

Mayo Clinic46 participantsStarted Aug 2012

Scottsdale, Arizona, United States

TERMINATEDPhase 131 miles

Molecular Regulation of Muscle Glucose Metabolism

NCT01581736

This protocol is being conducted to determine the mechanisms responsible for insulin resistance, obesity and type 2 diabetes.

ObesityType 2 Diabetes Mellitus

Mayo Clinic48 participantsStarted Apr 2012

Scottsdale, Arizona, United States

COMPLETEDPhase 231 miles

Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

NCT00500331

This is a dose-ranging study that will evaluate the efficacy, safety and tolerability of a range of doses of investigational product and pioglitazone, compared to placebo, administered as monotherapy over 12 weeks in treatment naive patients with T2DM

Diabetes Mellitus, Type 2

GlaxoSmithKline334 participantsStarted Jan 2007

Mesa, Arizona, United States • Hollywood, Florida, United States • Miami, Florida, United States +133 more locations

PreviousPage 14 of 25Next

Epigenetics and the Origin of Muscle Insulin Resistance in Humans

Molecular Regulation of Muscle Glucose Metabolism

Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

Diabetes Trials in Other Cities

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive

A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms

Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Type 2 Diabetics

Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes

A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients

Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II

Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

Reproducibility of HbA1c Measurement on the Aina HbA1c Monitoring System

Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers

PK Study of Dapagliflozin in Pediatric Subjects With T2DM

FreeStyle Libre Flash Accuracy Study

TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)

Extended Follow-Up After Islet Transplantation in T1D

Other Conditions in Arizona